These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4809259)

  • 1. Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
    Atkinson M; Hartley D; Lunts LH; Ritchie AC
    J Med Chem; 1974 Feb; 17(2):248-9. PubMed ID: 4809259
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of norepinephrine biosynthesis by -methyl amino acids in the guinea-pig vas deferens.
    Thoa NB; Johnson DG; Kopin IJ
    J Pharmacol Exp Ther; 1972 Jan; 180(1):71-7. PubMed ID: 4551586
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of alpha-methyl-DOPA metabolites in heart and brain of guinea pigs treated with alpha-methyl-tyrosine.
    Maître L
    Life Sci; 1965 Dec; 4(23):2249-56. PubMed ID: 5880875
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse.
    Porter CC; Totaro JA; Burcin A; Wynosky ER
    Biochem Pharmacol; 1966 May; 15(5):583-90. PubMed ID: 5961435
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive effects of alpha-methylated catecholamine analogues in the rat.
    Brunner H; Hedwall PR; Maître L; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):108-22. PubMed ID: 6039967
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
    Vazquez AJ; Sabelli HC
    Exp Neurol; 1975 Jan; 46(1):44-56. PubMed ID: 1109342
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 9. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF ALPHA-METHYL-DOPA ON MYOCARDIAL CATECHOLAMINES.
    MAITRE L; STAEHELIN M
    Experientia; 1963 Nov; 19():573-5. PubMed ID: 14101511
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of pyridoxal phosphate with tyrosine analogs.
    Zenker N
    J Med Chem; 1966 Nov; 9(6):826-8. PubMed ID: 4382028
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
    Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
    [No Abstract]   [Full Text] [Related]  

  • 13. Decarboxylation-dependent transamination catalyzed by mammalian 3,4-dihydroxyphenylalanine decarboxylase.
    O'Leary MH; Baughn RL
    J Biol Chem; 1977 Oct; 252(20):7168-73. PubMed ID: 561784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML; Lotti VJ; Clark CM; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression, by alpha-methyl-DOPA and alpha-methyl-p-tyrosine, of the anti-inflammatory action of aminopyrine.
    Jaques R
    Helv Physiol Pharmacol Acta; 1965; 23(3):311-4. PubMed ID: 5860614
    [No Abstract]   [Full Text] [Related]  

  • 16. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.
    Andén NE; Butcher SG; Engel J
    J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068
    [No Abstract]   [Full Text] [Related]  

  • 17. On the norepinephrine replacement by alpha-methyl-norepinephrine in the rat heart after treatment with alpha-methyl-DOPA.
    Maître L; Staehelin M
    Experientia; 1967 Oct; 23(10):810-1. PubMed ID: 6076302
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.
    HESS SM; CONNAMACHER RH; OZAKI M; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Nov; 134():129-38. PubMed ID: 13907002
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by alpha-methyl-dopa and alpha-methyl-metatyrosine.
    Andén NE; Fuxe K; Henning M
    Eur J Pharmacol; 1969 Dec; 8(3):302-9. PubMed ID: 5263681
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of the response of the isolated atria of guinea-pigs to tyramine and possible significance of beta-hydroxylation.
    Bhagat B; Gray L; Dhalla NS
    Nature; 1966 May; 210(5038):823-4. PubMed ID: 5958450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.